Status:
COMPLETED
Effects of Cacao Flavonoids in Long COVID-19 Patients (FLALOC)
Lead Sponsor:
Guillermo Ceballos Reyes
Collaborating Sponsors:
Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado
Conditions:
Long Covid19
Fatigue Syndrome, Chronic
Eligibility:
All Genders
30-70 years
Phase:
NA
Brief Summary
The study use a triple blind, placebo-controlled design enrolling male and female subjects between 30-70 yo to evaluate the effect of daily consumption of a cacao supplement on inflammation, endotheli...
Detailed Description
The study use a triple blind, placebo-controlled design enrolling male and female subjects between 30-70 yo distributed homogeneously at random in two groups: the control group (Placebo) and the inter...
Eligibility Criteria
Inclusion
- Post-COVID-19 patients, at least 6 months after symptom onset
- Chronic fatigue
Exclusion
- Allergy or intolerance caused by active ingredients
- Pregnancy or lactation
- BMI \>35
- chronic liver disease
- chronic kidney disease
Key Trial Info
Start Date :
August 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2024
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT06064838
Start Date
August 1 2023
End Date
September 30 2024
Last Update
October 1 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
C.E. Indianilla
Mexico City, Mexico City, Mexico